{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:44:04Z","timestamp":1792273444308,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82574159, 82173572"],"award-info":[{"award-number":["82574159, 82173572"]}]},{"name":"he Science and Technology Program of Hunan Province","award":["2026JK2006, 2026JJ80902, 2023JJ30430"],"award-info":[{"award-number":["2026JK2006, 2026JJ80902, 2023JJ30430"]}]},{"name":"the Department of Education of Hunan Province","award":["23A0075"],"award-info":[{"award-number":["23A0075"]}]},{"name":"the Hunan Chest Hospital - Hunan Normal University Joint Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12954-w","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:36:09Z","timestamp":1792233369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utilization of the CRISPR-Cas system for investigating tuberculosis drug resistance"],"prefix":"10.1007","volume":"53","author":[{"given":"Yanhui","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-9873","authenticated-orcid":false,"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"12954_CR1","unstructured":"Organization WH (2024) Global tuberculosis report 2024 Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240101531"},{"key":"12954_CR2","doi-asserted-by":"publisher","first-page":"Doc33","DOI":"10.3205\/dgkh000562","volume":"20","author":"M Michalik","year":"2025","unstructured":"Michalik M et al (2025) Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review. GMS Hyg Infect Control 20:Doc33. https:\/\/doi.org\/10.3205\/dgkh000562","journal-title":"GMS Hyg Infect Control"},{"issue":"14","key":"12954_CR3","doi-asserted-by":"publisher","first-page":"e03964","DOI":"10.1002\/adhm.202503964","volume":"15","author":"CS Carnero Canales","year":"2026","unstructured":"Carnero Canales CS et al (2026) Redefining Therapies for Drug-Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design. Adv Healthc Mater 15(14):e03964. https:\/\/doi.org\/10.1002\/adhm.202503964","journal-title":"Adv Healthc Mater"},{"issue":"3","key":"12954_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/antibiotics3030317","volume":"3","author":"JC Palomino","year":"2014","unstructured":"Palomino JC, Martin A (2014) Drug Resistance Mechanisms in Mycobacterium tuberculosis. Antibiot (Basel) 3(3):317\u2013340. https:\/\/doi.org\/10.3390\/antibiotics3030317","journal-title":"Antibiot (Basel)"},{"key":"12954_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/82_2012_279","volume":"374","author":"T Smith","year":"2013","unstructured":"Smith T, Wolff KA, Nguyen L (2013) Molecular biology of drug resistance in Mycobacterium tuberculosis. Curr Top Microbiol Immunol 374:53\u201380. https:\/\/doi.org\/10.1007\/82_2012_279","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"12954_CR6","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1021\/acs.accounts.0c00878","volume":"54","author":"V Singh","year":"2021","unstructured":"Singh V, Chibale K (2021) Strategies to Combat Multi-Drug Resistance in Tuberculosis. Acc Chem Res 54(10):2361\u20132376. https:\/\/doi.org\/10.1021\/acs.accounts.0c00878","journal-title":"Acc Chem Res"},{"issue":"10","key":"12954_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","volume":"22","author":"M Farhat","year":"2024","unstructured":"Farhat M et al (2024) Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol 22(10):617\u2013635. https:\/\/doi.org\/10.1038\/s41579-024-01025-1","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"12954_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/s1473-3099(15)00062-6","volume":"15","author":"TM Walker","year":"2015","unstructured":"Walker TM et al (2015) Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15(10):1193\u20131202. https:\/\/doi.org\/10.1016\/s1473-3099(15)00062-6","journal-title":"Lancet Infect Dis"},{"issue":"28","key":"12954_CR9","doi-asserted-by":"publisher","first-page":"e2301394120","DOI":"10.1073\/pnas.2301394120","volume":"120","author":"R Vargas Jr","year":"2023","unstructured":"Vargas R Jr. et al (2023) Phase variation as a major mechanism of adaptation in Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 120(28):e2301394120. https:\/\/doi.org\/10.1073\/pnas.2301394120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12954_CR10","doi-asserted-by":"publisher","unstructured":"Xu W et al (2017) Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 61(12). https:\/\/doi.org\/10.1128\/aac.01334-17","DOI":"10.1128\/aac.01334-17"},{"issue":"8","key":"12954_CR11","doi-asserted-by":"publisher","first-page":"e0052724","DOI":"10.1128\/spectrum.00527-24","volume":"12","author":"N Bhalla","year":"2024","unstructured":"Bhalla N, Nanda RK (2024) Pangenome-wide association study reveals the selective absence of CRISPR genes (Rv2816c-19c) in drug-resistant Mycobacterium tuberculosis. Microbiol Spectr 12(8):e0052724. https:\/\/doi.org\/10.1128\/spectrum.00527-24","journal-title":"Microbiol Spectr"},{"issue":"4","key":"12954_CR12","doi-asserted-by":"publisher","first-page":"e0064223","DOI":"10.1128\/msphere.00642-23","volume":"9","author":"C Gager","year":"2024","unstructured":"Gager C, Flores-Mireles AL (2024) Blunted blades: new CRISPR-derived technologies to dissect microbial multi-drug resistance and biofilm formation. mSphere 9(4):e0064223. https:\/\/doi.org\/10.1128\/msphere.00642-23","journal-title":"mSphere"},{"issue":"1","key":"12954_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12929-023-00932-4","volume":"30","author":"R Zein-Eddine","year":"2023","unstructured":"Zein-Eddine R et al (2023) The future of CRISPR in Mycobacterium tuberculosis infection. J Biomed Sci 30(1):34. https:\/\/doi.org\/10.1186\/s12929-023-00932-4","journal-title":"J Biomed Sci"},{"issue":"6","key":"12954_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrmicro2577","volume":"9","author":"KS Makarova","year":"2011","unstructured":"Makarova KS et al (2011) Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9(6):467\u2013477. https:\/\/doi.org\/10.1038\/nrmicro2577","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"12954_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","volume":"20","author":"A Pickar-Oliver","year":"2019","unstructured":"Pickar-Oliver A, Gersbach CA (2019) The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol 20(8):490\u2013507. https:\/\/doi.org\/10.1038\/s41580-019-0131-5","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"12954_CR16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","volume":"93","author":"YG Kim","year":"1996","unstructured":"Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 93(3):1156\u20131160. https:\/\/doi.org\/10.1073\/pnas.93.3.1156","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5959","key":"12954_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.1178817","volume":"326","author":"MJ Moscou","year":"2009","unstructured":"Moscou MJ, Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326(5959):1501. https:\/\/doi.org\/10.1126\/science.1178817","journal-title":"Science"},{"issue":"3","key":"12954_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cell.2017.04.005","volume":"169","author":"AC Komor","year":"2017","unstructured":"Komor AC, Badran AH, Liu DR (2017) CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell 169(3):559. https:\/\/doi.org\/10.1016\/j.cell.2017.04.005","journal-title":"Cell"},{"issue":"6213","key":"12954_CR19","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096. https:\/\/doi.org\/10.1126\/science.1258096","journal-title":"Science"},{"issue":"46","key":"12954_CR20","doi-asserted-by":"publisher","first-page":"13508","DOI":"10.1002\/anie.201504741","volume":"54","author":"M Kirchner","year":"2015","unstructured":"Kirchner M, Schneider S (2015) CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering. Angew Chem Int Ed Engl 54(46):13508\u201313514. https:\/\/doi.org\/10.1002\/anie.201504741","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"12954_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","volume":"18","author":"KS Makarova","year":"2020","unstructured":"Makarova KS et al (2020) Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol 18(2):67\u201383. https:\/\/doi.org\/10.1038\/s41579-019-0299-x","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"12954_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12896-019-0509-7","volume":"19","author":"S Najah","year":"2019","unstructured":"Najah S et al (2019) Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci. BMC Biotechnol 19(1):18. https:\/\/doi.org\/10.1186\/s12896-019-0509-7","journal-title":"BMC Biotechnol"},{"issue":"1","key":"12954_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13765-023-00771-9","volume":"66","author":"US Kadam","year":"2023","unstructured":"Kadam US et al (2023) Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets. Appl Biol Chem 66(1):13. https:\/\/doi.org\/10.1186\/s13765-023-00771-9","journal-title":"Appl Biol Chem"},{"key":"12954_CR24","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.2147\/idr.S370869","volume":"15","author":"S Tao","year":"2022","unstructured":"Tao S et al (2022) The Application of the CRISPR-Cas System in Antibiotic Resistance. Infect Drug Resist 15:4155\u20134168. https:\/\/doi.org\/10.2147\/idr.S370869","journal-title":"Infect Drug Resist"},{"key":"12954_CR25","doi-asserted-by":"publisher","first-page":"128232","DOI":"10.1016\/j.micres.2025.128232","volume":"298","author":"R Zhang","year":"2025","unstructured":"Zhang R et al (2025) Advancements in CRISPR-Cas-based strategies for combating antimicrobial resistance. Microbiol Res 298:128232. http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.micres.2025.128232","journal-title":"Microbiol Res"},{"issue":"3","key":"12954_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41587-019-0387-5","volume":"38","author":"M Jost","year":"2020","unstructured":"Jost M et al (2020) Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs. Nat Biotechnol 38(3):355\u2013364. https:\/\/doi.org\/10.1038\/s41587-019-0387-5","journal-title":"Nat Biotechnol"},{"key":"12954_CR27","doi-asserted-by":"publisher","unstructured":"Yang C et al (2024) The Current Situation and Development Prospect of Whole-Genome Screening. Int J Mol Sci 25(1). https:\/\/doi.org\/10.3390\/ijms25010658","DOI":"10.3390\/ijms25010658"},{"issue":"6","key":"12954_CR28","doi-asserted-by":"publisher","first-page":"189212","DOI":"10.1016\/j.bbcan.2024.189212","volume":"1879","author":"Y He","year":"2024","unstructured":"He Y et al (2024) Developing pioneering pharmacological strategies with CRISPR\/Cas9 library screening to overcome cancer drug resistance. Biochim Biophys Acta Rev Cancer 1879(6):189212. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189212","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"13","key":"12954_CR29","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1128\/aem.00873-15","volume":"81","author":"T Xu","year":"2015","unstructured":"Xu T et al (2015) Efficient Genome Editing in Clostridium cellulolyticum via CRISPR-Cas9 Nickase. Appl Environ Microbiol 81(13):4423\u20134431. https:\/\/doi.org\/10.1128\/aem.00873-15","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"12954_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nsmb915","volume":"12","author":"C Gong","year":"2005","unstructured":"Gong C et al (2005) Mechanism of nonhomologous end-joining in mycobacteria: a low-fidelity repair system driven by Ku, ligase D and ligase C. Nat Struct Mol Biol 12(4):304\u2013312. https:\/\/doi.org\/10.1038\/nsmb915","journal-title":"Nat Struct Mol Biol"},{"key":"12954_CR31","doi-asserted-by":"publisher","unstructured":"Yan MY et al (2020) A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis. mBio 11(1). https:\/\/doi.org\/10.1128\/mBio.02364-19","DOI":"10.1128\/mBio.02364-19"},{"key":"12954_CR32","doi-asserted-by":"publisher","first-page":"16274","DOI":"10.1038\/nmicrobiol.2016.274","volume":"2","author":"JM Rock","year":"2017","unstructured":"Rock JM et al (2017) Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat Microbiol 2:16274. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.274","journal-title":"Nat Microbiol"},{"issue":"9","key":"12954_CR33","doi-asserted-by":"publisher","first-page":"e0090422","DOI":"10.1128\/aac.00904-22","volume":"66","author":"NC Poulton","year":"2022","unstructured":"Poulton NC et al (2022) Mutations in rv0678 Confer Low-Level Resistance to Benzothiazinone DprE1 Inhibitors in Mycobacterium tuberculosis. Antimicrob Agents Chemother 66(9):e0090422. https:\/\/doi.org\/10.1128\/aac.00904-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"39","key":"12954_CR34","doi-asserted-by":"publisher","first-page":"e2400176","DOI":"10.1002\/advs.202400176","volume":"11","author":"MY Yan","year":"2024","unstructured":"Yan MY et al (2024) CRISPR Screening and Comparative LC-MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis. Adv Sci (Weinh) 11(39):e2400176. https:\/\/doi.org\/10.1002\/advs.202400176","journal-title":"Adv Sci (Weinh)"},{"issue":"47","key":"12954_CR35","doi-asserted-by":"publisher","first-page":"eadd5907","DOI":"10.1126\/sciadv.add5907","volume":"8","author":"MY Yan","year":"2022","unstructured":"Yan MY et al (2022) Application of combined CRISPR screening for genetic and chemical-genetic interaction profiling in Mycobacterium tuberculosis. Sci Adv 8(47):eadd5907. https:\/\/doi.org\/10.1126\/sciadv.add5907","journal-title":"Sci Adv"},{"issue":"6","key":"12954_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41564-022-01130-y","volume":"7","author":"S Li","year":"2022","unstructured":"Li S et al (2022) CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis. Nat Microbiol 7(6):766\u2013779. https:\/\/doi.org\/10.1038\/s41564-022-01130-y","journal-title":"Nat Microbiol"},{"key":"12954_CR37","doi-asserted-by":"publisher","unstructured":"Wang X et al (2026) Genome scale CRISPRi reveals both shared and strain-specific vulnerabilities in genetically diverse drug-resistant strains of Mycobacterium tuberculosis. Nat Commun 17(1). https:\/\/doi.org\/10.1038\/s41467-026-73952-x","DOI":"10.1038\/s41467-026-73952-x"},{"issue":"1","key":"12954_CR38","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1038\/s41467-024-54072-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X et al (2024) Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis. Nat Commun 15(1):9791. https:\/\/doi.org\/10.1038\/s41467-024-54072-w","journal-title":"Nat Commun"},{"key":"12954_CR39","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/ncomms7267","volume":"6","author":"E Choudhary","year":"2015","unstructured":"Choudhary E et al (2015) Gene silencing by CRISPR interference in mycobacteria. Nat Commun 6:6267. https:\/\/doi.org\/10.1038\/ncomms7267","journal-title":"Nat Commun"},{"issue":"11","key":"12954_CR40","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/nprot.2013.132","volume":"8","author":"MH Larson","year":"2013","unstructured":"Larson MH et al (2013) CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc 8(11):2180\u20132196. https:\/\/doi.org\/10.1038\/nprot.2013.132","journal-title":"Nat Protoc"},{"issue":"3","key":"12954_CR41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cell.2021.01.019","volume":"184","author":"LS Qi","year":"2021","unstructured":"Qi LS et al (2021) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 184(3):844. https:\/\/doi.org\/10.1016\/j.cell.2021.01.019","journal-title":"Cell"},{"issue":"1","key":"12954_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/nar\/gku1257","volume":"43","author":"D Rath","year":"2015","unstructured":"Rath D et al (2015) Efficient programmable gene silencing by Cascade. Nucleic Acids Res 43(1):237\u2013246. https:\/\/doi.org\/10.1093\/nar\/gku1257","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"12954_CR43","doi-asserted-by":"publisher","first-page":"e0026124","DOI":"10.1128\/aac.00261-24","volume":"68","author":"AH Roberts","year":"2024","unstructured":"Roberts AH et al (2024) EfpA is required for regrowth of Mycobacterium tuberculosis following isoniazid exposure. Antimicrob Agents Chemother 68(8):e0026124. https:\/\/doi.org\/10.1128\/aac.00261-24","journal-title":"Antimicrob Agents Chemother"},{"key":"12954_CR44","doi-asserted-by":"publisher","first-page":"102665","DOI":"10.1016\/j.tube.2025.102665","volume":"154","author":"FB Carlos Alonso","year":"2025","unstructured":"Carlos Alonso FB et al (2025) CRISPRi-mediated repression of efflux pumps reveals Rv1258c as a key contributor to pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 154:102665. https:\/\/doi.org\/10.1016\/j.tube.2025.102665","journal-title":"Tuberculosis (Edinb)"},{"key":"12954_CR45","doi-asserted-by":"publisher","first-page":"1089911","DOI":"10.3389\/fcimb.2023.1089911","volume":"13","author":"C Silveiro","year":"2023","unstructured":"Silveiro C et al (2023) CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival. Front Cell Infect Microbiol 13:1089911. https:\/\/doi.org\/10.3389\/fcimb.2023.1089911","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"12954_CR46","doi-asserted-by":"publisher","first-page":"100990","DOI":"10.1016\/j.jbc.2021.100990","volume":"297","author":"N Fleck","year":"2021","unstructured":"Fleck N, Grundner C (2021) A Cas12a-based CRISPR interference system for multigene regulation in mycobacteria. J Biol Chem 297(2):100990. https:\/\/doi.org\/10.1016\/j.jbc.2021.100990","journal-title":"J Biol Chem"},{"issue":"5","key":"12954_CR47","doi-asserted-by":"publisher","first-page":"e1011408","DOI":"10.1371\/journal.pcbi.1011408","volume":"20","author":"S Choudhery","year":"2024","unstructured":"Choudhery S et al (2024) A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens. PLoS Comput Biol 20(5):e1011408. https:\/\/doi.org\/10.1371\/journal.pcbi.1011408","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"12954_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nbt.2842","volume":"32","author":"JD Sander","year":"2014","unstructured":"Sander JD, Joung JK (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32(4):347\u2013355. https:\/\/doi.org\/10.1038\/nbt.2842","journal-title":"Nat Biotechnol"},{"issue":"4","key":"12954_CR49","doi-asserted-by":"publisher","first-page":"e0228924","DOI":"10.1128\/spectrum.02289-24","volume":"13","author":"C Fang","year":"2025","unstructured":"Fang C et al (2025) GrcC1 mediates low-level resistance to multiple drugs in M. marinum, M. abscessus, and M. smegmatis. Microbiol Spectr 13(4):e0228924. https:\/\/doi.org\/10.1128\/spectrum.02289-24","journal-title":"Microbiol Spectr"},{"key":"12954_CR50","doi-asserted-by":"publisher","unstructured":"Zhang H et al (2025) Dual Mutations in MSMEG_0965 and MSMEG_1380 Confer High-Level Resistance to Bortezomib and Linezolid by Both Reducing Drug Intake and Increasing Efflux in Mycobacterium smegmatis. Int J Mol Sci 26(8). https:\/\/doi.org\/10.3390\/ijms26083779","DOI":"10.3390\/ijms26083779"},{"issue":"7603","key":"12954_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC et al (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533(7603):420\u2013424. https:\/\/doi.org\/10.1038\/nature17946","journal-title":"Nature"},{"issue":"7681","key":"12954_CR52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM et al (2017) Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551(7681):464\u2013471. https:\/\/doi.org\/10.1038\/nature24644","journal-title":"Nature"},{"issue":"11","key":"12954_CR53","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1042\/bcj20170793","volume":"475","author":"A Eid","year":"2018","unstructured":"Eid A, Alshareef S, Mahfouz MM (2018) CRISPR base editors: genome editing without double-stranded breaks. Biochem J 475(11):1955\u20131964. https:\/\/doi.org\/10.1042\/bcj20170793","journal-title":"Biochem J"},{"issue":"7","key":"12954_CR54","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1093\/nar\/gkac201","volume":"50","author":"D Zhao","year":"2022","unstructured":"Zhao D et al (2022) Imperfect guide-RNA (igRNA) enables CRISPR single-base editing with ABE and CBE. Nucleic Acids Res 50(7):4161\u20134170. https:\/\/doi.org\/10.1093\/nar\/gkac201","journal-title":"Nucleic Acids Res"},{"key":"12954_CR55","doi-asserted-by":"publisher","first-page":"734436","DOI":"10.3389\/fgeed.2021.734436","volume":"3","author":"XY Ding","year":"2021","unstructured":"Ding XY et al (2021) Programmable Base Editing in Mycobacterium tuberculosis Using an Engineered CRISPR RNA-Guided Cytidine Deaminase. Front Genome Ed 3:734436. https:\/\/doi.org\/10.3389\/fgeed.2021.734436","journal-title":"Front Genome Ed"},{"key":"12954_CR56","doi-asserted-by":"publisher","unstructured":"Zhang H et al (2022) PAM-Expanded Streptococcus thermophilus Cas9 C-to-T and C-to-G Base Editors for Programmable Base Editing in Mycobacteria. Engineering 15:67\u201377. https:\/\/doi.org\/10.1016\/j.eng.2022.02.013","DOI":"10.1016\/j.eng.2022.02.013"},{"issue":"1","key":"12954_CR57","doi-asserted-by":"publisher","first-page":"103573","DOI":"10.1016\/j.isci.2021.103573","volume":"25","author":"MB McNeil","year":"2022","unstructured":"McNeil MB et al (2022) Multiplexed transcriptional repression identifies a network of bactericidal interactions between mycobacterial respiratory complexes. iScience 25(1):103573. https:\/\/doi.org\/10.1016\/j.isci.2021.103573","journal-title":"iScience"},{"issue":"5","key":"12954_CR58","doi-asserted-by":"publisher","first-page":"e0061026","DOI":"10.1128\/mbio.00610-26","volume":"17","author":"ME Theriault","year":"2026","unstructured":"Theriault ME et al (2026) Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis. mBio 17(5):e0061026. https:\/\/doi.org\/10.1128\/mbio.00610-26","journal-title":"mBio"},{"issue":"3","key":"12954_CR59","doi-asserted-by":"publisher","first-page":"949","DOI":"10.13345\/j.cjb.240865","volume":"41","author":"Y Mao","year":"2025","unstructured":"Mao Y et al (2025) [Artificial intelligence-assisted design, mining, and modification of CRISPR-Cas systems]. Sheng Wu Gong Cheng Xue Bao 41(3):949\u2013967. https:\/\/doi.org\/10.13345\/j.cjb.240865","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"1","key":"12954_CR60","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/s41598-022-06449-4","volume":"12","author":"X Kuang","year":"2022","unstructured":"Kuang X et al (2022) Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN. Sci Rep 12(1):2427. https:\/\/doi.org\/10.1038\/s41598-022-06449-4","journal-title":"Sci Rep"},{"key":"12954_CR61","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ebiom.2019.04.016","volume":"43","author":"ML Chen","year":"2019","unstructured":"Chen ML et al (2019) Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction. EBioMedicine 43:356\u2013369. https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.016","journal-title":"EBioMedicine"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12954-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:02:15Z","timestamp":1792270935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12954-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12954"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12954-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"12 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Generative AI use","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1759"}}